Impact of COVID-19 delays on skin cancer worry and Mohs micrographic surgery for keratinocytic carcinoma - 17/12/21
Doi : 10.1016/j.jaad.2021.11.052
Emily Stamell Ruiz, MD, MPH a, ⁎ 
, Inge J. Veldhuizen, MD b, Aleisa Abdullah, MD b, Anthony Rossi, MD b, Kishwer S. Nehal, MD b, Chrysalyne Schmults, MD, MSCE a, Abigail Waldman, MD a, Erica H. Lee, MD b
, Inge J. Veldhuizen, MD b, Aleisa Abdullah, MD b, Anthony Rossi, MD b, Kishwer S. Nehal, MD b, Chrysalyne Schmults, MD, MSCE a, Abigail Waldman, MD a, Erica H. Lee, MD b a Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts
b Dermatology Service, Memorial Sloan Kettering Cancer Center, New York, New York
∗Reprint requests: Emily Stamell Ruiz, MD, MPH, Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, 1153 Centre Street Suite 4J, Boston, MA 02130Department of DermatologyBrigham and Women's HospitalHarvard Medical School1153 Centre Street Suite 4JBostonMA02130
Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.
Connectez-vous pour en bénéficier!
Sous presse. Épreuves corrigées par l'auteur.
Disponible en ligne depuis le Friday 17 December 2021
Cet article a été publié dans un numéro de la revue, cliquez ici pour y accéder
Cet article a été publié dans un numéro de la revue, cliquez ici pour y accéder
Key words : basal cell carcinoma, COVID-19, cutaneous squamous cell carcinoma, Mohs micrographic surgery
| Funding sources: This research was funded, in part, by the National Institutes of Health/National Cancer Institute Cancer Center Support Grant P30 CA008748. The funder had no role in the design and conduct of the study: collection, management, analysis, and interpretation of the data; preparation, review or approval of the manuscript; and decision to submit the manuscript for publication. |
|
| IRB approval status: Reviewed and approved by the Partners (2020P001143) and Memorial Sloan Kettering (18-168) Cancer Center Human Research Office. |
© 2021
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Bienvenue sur EM-consulte, la référence des professionnels de santé.